Literature DB >> 19579692

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.

Pelin Yüksel1, Ozlem Tansel.   

Abstract

Mutations in the pyrazinamidase (PZase) gene (pncA) are considered the major mechanism of pyrazinamide (PZA) resistance in Mycobacterium tuberculosis. The aim of this study was designed to determine pncA mutations among ten PZA resistant and two PZA susceptible M. tuberculosis strains from Turkey and also to compare the PZase activity of them with the genotype. All isolates were identified by BACTEC NAP (P-nitro-alpha-acetylamino-beta-hydroxy-propiophenone) test and PCR-RFLP (Polymerase Chain Reaction- Restriction Fragment Length Polymorphism) method. Drug sensitivity tests were performed by BACTEC system. PncA mutations were detected by DNA sequence analysis. No mutation was detected in two PZA susceptible and three out of ten PZA resistant strains. While, two of the PZA resistant strains had mutations in the same region (Gly24Asp), two of the PZA resistant strains had mutations in different regions (Thr160Lys), (His51Pro). Three of the PZA resistant strains had frameshift as a 167 bp deletion at nucleotide position 102. As a result, we detected two new mutations and a frameshift which may be responsible for PZA resistance in this study different from the other studies which previously 51st codon mutation was reported.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579692

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  12 in total

1.  Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis.

Authors:  Derrick R Seiner; Subray S Hegde; John S Blanchard
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.

Authors:  Farahnoosh Doustdar; Mohammad Pazhang; Faramarz Mehrnejad; Mehrnoosh Safarzadeh; Davod Rabiei; Nader Chaparzadeh; Hanieh Falahati; Mohammad Mir-Derikvand
Journal:  Protein J       Date:  2015-06       Impact factor: 2.371

Review 3.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 4.  Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.

Authors:  Kwok Chiu Chang; Wing Wai Yew; Ying Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

Review 5.  Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.

Authors:  Sarah M Ramirez-Busby; Faramarz Valafar
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

6.  Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis.

Authors:  Miguel Quiliano; Andres Hazaet Gutierrez; Robert Hugh Gilman; César López; Wilfredo Evangelista; Jun Sotelo; Patricia Sheen; Mirko Zimic
Journal:  Bioinformation       Date:  2011-07-19

7.  Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study.

Authors:  M J Nasiri; F Fardsanei; M Arshadi; B Deihim; Farima Khalili; M Dadashi; M Goudarzi; M Mirsaeidi
Journal:  New Microbes New Infect       Date:  2021-05-05

Review 8.  A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.

Authors:  Michael G Whitfield; Heidi M Soeters; Robin M Warren; Talita York; Samantha L Sampson; Elizabeth M Streicher; Paul D van Helden; Annelies van Rie
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

9.  Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of ethA as a Mechanism of Ethionamide Resistance.

Authors:  Lynne de Welzen; Vegard Eldholm; Kashmeel Maharaj; Abigail L Manson; Ashlee M Earl; Alexander S Pym
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

10.  Whole genome sequencing data of 1110 Mycobacterium tuberculosis isolates identifies insertions and deletions associated with drug resistance.

Authors:  Xi Zeng; Jamie Sui-Lam Kwok; Kevin Yi Yang; Kenneth Siu-Sing Leung; Mai Shi; Zhiyuan Yang; Wing-Cheong Yam; Stephen Kwok-Wing Tsui
Journal:  BMC Genomics       Date:  2018-05-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.